Examkin

Question

Difficulty: MediumEndocrinology and Metabolism

A 26-year-old woman, gravida 1, para 0, comes to the clinic at 9 weeks gestation for a routine prenatal visit. The patient reports mild morning nausea and breast tenderness but otherwise feels well. She has no history of thyroid disease and does not take any medications other than a standard prenatal vitamin. She reports no palpitations, tremors, heat intolerance, or weight loss. Vital signs are within normal limits. Physical examination reveals a normal-sized thyroid gland without palpable nodules, goiter, or bruits. Deep tendon reflexes are normal. Laboratory evaluation shows the following:

Laboratory TestResultReference Range
Hemoglobin11.5 g/dL11.0–15.0 g/dL
Thyroid-stimulating hormone (TSH)0.05 mU/L0.4–4.0 mU/L
Free thyroxine (Free T4)1.3 ng/dL0.9–1.7 ng/dL
Total thyroxine (Total T4)14.2 mcg/dL5.0–12.0 mcg/dL

Which of the following is the most appropriate next step in management?

  1. Reassurance and routine prenatal careAnswer
  2. B
    Initiation of propylthiouracil therapy
  3. C
    Measurement of thyroid-stimulating immunoglobulins
  4. D
    Measurement of free triiodothyronine (Free T3)
  5. E
    Radionuclide thyroid scan

Answer

Reassurance and routine prenatal care
The correct management is reassurance and observation because the patient's laboratory results reflect normal physiologic adaptations to pregnancy. In the first trimester, high levels of human chorionic gonadotropin (hCG) can directly stimulate the TSH receptor due to structural similarities, resulting in increased thyroid hormone output and a compensatory suppression of TSH (gestational transient thyrotoxicosis). Concurrently, rising estrogen levels increase hepatic synthesis of thyroxine-binding globulin (TBG). This increases the body's pool of bound thyroid hormone, raising the Total T4. Crucially, the biologically active Free T4 level remains in the normal range, preventing clinical thyrotoxicosis. Because the patient lacks symptoms (e.g., palpitations, weight loss) and has normal free T4 levels, no medical intervention or further diagnostic workup is needed.

Step-by-Step Solution

1
Evaluate the clinical presentation.
The patient is completely asymptomatic aside from normal early-pregnancy nausea. She has no physical signs of thyrotoxicosis (e.g., tachycardia, tremor, goiter).
Differentiating between pathologic hyperthyroidism (which requires treatment) and physiologic changes of pregnancy (which do not) relies heavily on the presence or absence of clinical symptoms.
2
Interpret the thyroid laboratory panel in the context of pregnancy.
The patient has a suppressed TSH, elevated Total T4, but a normal Free T4.
During the first trimester, elevated hCG shares a structural subunit with TSH and weakly stimulates the TSH receptor, leading to increased endogenous thyroid hormone production and a compensatory drop in TSH (gestational transient thyrotoxicosis). Concurrently, increased estrogen stimulates hepatic production of thyroxine-binding globulin (TBG), which binds circulating thyroid hormone, raising Total T4 levels while biologically active Free T4 remains normal.
3
Determine the appropriate management.
Observation and routine prenatal care.
Because the free T4 remains within normal limits and the patient is asymptomatic, these findings confirm normal physiologic adaptations to pregnancy. No antithyroid medications or further diagnostic testing is required.

Key Concept

Normal physiologic changes of thyroid function in pregnancy include an estrogen-induced increase in TBG (elevating total T4) and an hCG-induced weak stimulation of the TSH receptor (suppressing TSH), while free T4 remains essentially normal.
Rate this question

Topics

Endocrinology and Metabolism

More questions from this topic